News

49 First Line Products Including Topamax, Effexor XR, Lipitor, Plavix and Cymbalta To Lose Patent Protection Over The Next Five […]

Company Expected to Report Its Third Consecutive Quarter of Record Revenue As Sales of Generic Pharmaceutical Products Continue To Increase

BUENA PARK, CA, August 30, 2010 – SOHM, Inc. (Pink Sheets: SHMN), announced today its generic pharmaceutical marketing program received

SOHM Continues To Broaden International Sales Channels In Southeast Asia BUENA PARK, CA, August 27, 2010 – SOHM, Inc. (Pink

 Consumer Adoption of SOHM’s Private Label Generic Pharmaceutical Products Driving Unprecedented Corporate Revenue Growth BUENA PARK, CA, August 26,

Sales Continue To Grow in India’s $10 Billion Pharmaceutical Market With Increased Penetration Into Global Emerging Markets BUENA PARK, CA,

BUENA PARK, CA–(Marketwire – 07/13/10) – SOHM, Inc. (Pinksheets:SHMN – News), a generic pharmaceutical manufacturer that produces and markets generic

BUENA PARK, CA–(Marketwire – 06/07/10) – SOHM, Inc. (Pinksheets:SHMN – News), a generic pharmaceutical manufacturer that produces and markets generic

BUENA PARK, CA–(Marketwire – 05/27/10) – SOHM, Inc. (Pinksheets:SHMN – News), a generic pharmaceutical manufacturer that produces and markets generic

BUENA PARK, CA, May 25, 2010 – SOHM, Inc. (Pink Sheets: SHMN), a generic pharmaceutical manufacturer that produces and markets